Brief: Glycomimetics Announces Clinical Data In Acute Myeloid Leukemia
12/12/2022 15:21
Dec 12 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS ANNOUNCES NEW UPROLESELAN CLINICAL DATA IN
BOTH
FRONTLINE UNFIT AND TREATED SECONDARY ACUTE MYELOID LEUKEMIA
PRESENTED AT ASH ANNUAL MEETING
Source text for Eikon: ID:nBwbZ39l2a
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering